Report Categories
View AllRecent Articles
View All
RIGL Rigel Pharmaceuticals Inc climbs two percent after Q4 2025 results even as EPS falls short of analyst forecasts
IQV IQVIA Holdings Inc posts narrow Q4 2025 EPS miss as shares climb on positive investor sentiment
The one number that tells PagSeguro PAGS whole earnings story PagSeguro Posts Modest EPS Beat Revenue Climbs
Chinas Renewable Energy and Energy Security Strategy Performance Amid Geopolitical Oil Shocks
What Innoviz INVZ management focus reveals about priorities Parabolic 20260506
The opportunity most miss about Sterling Infrastructure STRL Investor Concern 20260508
REVB Revelation Biosciences reports vastly wider Q4 2025 loss than estimates shares end flat for the trading day
External Links
Mineralys Therapeutics Q1 2026 Earnings Narrowed Loss Per Share as Pipeline Progress Continues
Trevi Therapeutics Q1 2026 Earnings Narrowing Losses but Trial Failures Weigh on Sentiment
PrimeEnergy Resources PNRG Q4 2025 Earnings Modest EPS Beat Amid Quiet Quarter Shares Edge Higher
Sonida Senior Living Q1 2026 Earnings Significant EPS Miss Clouds NearTerm Outlook Stock Shows Resilience
RXO Reports Continued Surge in Truckload Spot Market During Second Quarter
VNT Q1 2026 Earnings EPS Slightly Misses Estimates Shares Rise on Strategic Progress
TGS Q1 2026 Earnings Staggering EPS Beat of 319 Sends Stock Higher